PharmaTutor (December- 2013)
ISSN: 2347 - 7881
Received On: 07/11/2013; Accepted On: 19/11/2013; Published On: 20/12/2013
Authors: Ramesh Babu.Pedada1, Eukondalu Vanka1, A.M.S.Sudhakar Babu1, Prasannakumar Desu1, P.Ramaa Bharathi1, P.Venkateawara.rao2
1 Department of Pharmaceutics, 2 Department of Pharmaceutical Analysis,
A.M.Reddy Memorial College of pharmacy, Narasaraopet, Guntur (Dt), Andhra Pradesh, India.
ABSTRACT: Enhancement of solubility, dissolution rate and bioavailability of drug is a very challenging task in drug development, nearly 40% of the new chemical entities currently being discovered are poorly water soluble drugs. Aqueous solubility of any therapeutically active substance is a key property as it governs dissolution, absorption and thus the in vivo efficacy. Orally administered drugs completely absorb only when they show fair solubility in gastric medium and such drugs shows good bioavailability. The solubility and dissolution properties of drugs play an important role in the process of formulation development. Problem of solubility is a major challenge for formulation scientist which can be solved by different technological approaches during the pharmaceutical product development work. The present review deals in detail about the solubilisation by surfactants, cosolvents, complexation for the improvement of solubility of poorly water soluble drugs.
How to cite this article: Pedada RB, Vanka E, A.M.S.Sudhakar Babu, Desu PK, Bharathi PR, Rao PV, Enhancement of Solubility; an Over View, PharmaTutor, 2013, 1(2), 60-74
[ABSTRACT WITH CITATION] [VIEW AS HTML]
REFERENCES:
1.Adam M. Persky and JeffreyA.Hughes, Solutions and Solubility. cop.ufl.edu/safezone/prokai/pha5100/pha5110.htm
2.David Attwood, Alexander T. Florence; Text book of Physical Pharmacy, 2008. (Pg. No.43-60)
3.Carlota Oliveira Rangel-Yagui , Adalberto Pessoa Junior, Leoberto Costa Tavares; Micellarsolubilization of drugs; J Pharm PharmaceutSci (cspscanada.org) 2005, 8(2):147-163
4.James Swarbrick ; Encyclopedia of Pharmaceutical Technology, Third Edition Volume 1. (Pg. No.811-3394)
5.Leon Lachman, Herbert A. Lieberman; The theory and practice of Industrial Pharmacy, 2009 (Pg. No.462-464)
6.Yalkwoski ;Solubilisation techniques of non electrolytes, (Pg. No.1-157)
7. Martin, A, Bustamanate, P, and Chun, A, H, C,“Physical Pharmacy” B.I. Wavely Pvt. Ltd, New Delhi, 1994; 4, 223.
8.Osol, A, (Eds.) in: “Remington’s Pharmaceutical sciences” Mack Publishing Company, Eastern Pennsylvania, 1990; 18, 203.
9.Neuberg, C, Hydrotrophy, Biochem J. Pharm, 1989; 75(7), 577.
10.Gennaro A.R. editors. Remington, the science and practice of pharmacy, 21st ed. Lippincott, Williams & Wilkins, 2005; 867-868.
11.Fiese E.F, Hagen T.A. Preformulation. In: Lachman L, Liberman H.A, Kanig J.L, editors. The theory and practice of industrial pharmacy. 3rd ed. Bombay: Varghees Publication House, 1990; 171-196.
12. Allen L.V, Popovich, N.G, Ansel H.C., Ansel’s Pharmaceutical Dosage Forms and Drug Delivery Systems, Lippincott, Williams & Wilkins 2005; 100-101.
13.Aulton M.E., Pharmaceutics, The science of dosage form design, 2nd edition, Churchill Livingstone, London, 2002,113 – 138, 234 – 252.
14.Michael Hite, Lead Research Associate, Stephen Turner, Oral Delivery of Poorly Soluble Drugs 400, Pharmaceutical Manufacturing and Packing Sourcer Summer ‘03 issue. Samedan Ltd. 2003.
15.SheereBanga, GarimaChawla and Arvind K Bansal, New Trends in the Crystallisation of Active Pharmaceutical Ingredients, Business briefing: Pharmagenerics, 2004, 70-74.
16.Crystallization process using ultrasound, United States Patent 20020031577.
17.Vasu Kumar Kakumanu and Arvind K Bansal, Supercritical Fluid Technology in Pharmaceutical Research, Business briefing: Labtech, 2004, 71-73.
18.Irene Pasquali, RuggeroBettini, Ferdinando Giordano, Solid-state chemistry and particle engineering with supercritical fluids in pharmaceutics,European journal of pharmaceutical sciences 2006, 27,299-310
19.Hamsaraj Karanth, 1VikramSubrayaShenoy and RayasaRamachandra Murthy, Industrially Feasible Alternative Approaches in the Manufacture of Solid Dispersions: A Technical Report, AAPS PharmSciTech 2006; 7 (4) Article 87.
20. M. Perrut, J. Jung, F. Leboeuf, Enhancement of dissolution rate of poorly soluble active ingredients by supercritical fluid processes Part II: Preparation of composite particles, International Journal of Pharmaceutics, 2005, 288, 11–16.
21.Bhupendra G. Prajapati, Rakesh P. Patel, Ritesh B. Patel, Girish, N. Patel, Hitesh R. Patel and Dr. Madhabhai Patel, Novel Pharmaceutical Methods Improve one of the Principal Pharmacokinetic Properties of Lipophilic Drug, pharmaquality.com
.png)
